Carl Zeiss Meditec AG (CZMWY)
Carl Zeiss Meditec AG operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Jena, TH, DE. The stock last traded at $34.45, down 3.83% on the session, giving a market capitalisation of $3.02B. On trailing twelve-month figures it carries a trailing P/E of 21.93, a net margin of 3.4%. Its beta of 1.46 implies it has historically moved more than the broad market.
Carl Zeiss Meditec AG functions as a prominent global medical technology firm, conducting its operations across Germany, other European nations, the United States, and various Asian markets. Its business is organized into two principal divisions: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment provides an array of products and solutions tailored for the diagnosis and therapeutic management of ocular conditions, including specialized systems and essential consumables for cataract, retinal, and refractive surgical procedures. This division serves ophthalmologists, optometrists, and medical and surgical professionals in hospitals and ambulatory surgery centers. The Microsurgery segment focuses on delivering advanced visualization tools vital for intricate surgical interventions, additionally supplying specialized solutions for ear, nose, and throat (ENT), plastic and reconstructive, dental, and spinal surgeries. This segment supports a diverse group of medical practitioners across various disciplines, as well as healthcare institutions. Established in 1846 and headquartered in Jena, Germany, the company operates as a subsidiary of Carl Zeiss AG.
Carl Zeiss Meditec AG is most often compared with the following Healthcare names: